Affirm
AFRM
613 hedge funds and large institutions have $16.6B invested in Affirm in 2025 Q3 according to their latest regulatory filings, with 151 funds opening new positions, 220 increasing their positions, 168 reducing their positions, and 93 closing their positions.
62% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 93
31% more repeat investments, than reductions
Existing positions increased: 220 | Existing positions reduced: 168
9% more funds holding
Funds holding: 561 → 613 (+52)
7% more capital invested
Capital invested by funds: $15.5B → $16.6B (+$1.09B)
0.23% more ownership
Funds ownership: 79.46% → 79.69% (+0.23%)
9% less call options, than puts
Call options by funds: $1.4B | Put options by funds: $1.55B
46% less funds holding in top 10
Funds holding in top 10: 28 → 15 (-13)
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$246M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$228M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$199M |
| 4 |
BlackRock
New York
|
+$157M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$108M |
Top Sellers
AFRM Hedge Fund Activity: Q3 2025 in Review
613 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Affirm (AFRM) for Q3 2025, worth a combined $16.6B — up 7.1% from $15.5B a quarter earlier.
Buyers outnumbered sellers: 151 funds opened new AFRM positions and 93 closed out — a net gain of 58 holders — while 220 added to existing stakes and 168 trimmed.
The largest buyer was Invesco, adding an estimated $246M. The largest seller was T. Rowe Price Associates, cutting an estimated $197M.
- 613 institutional investors held Affirm (AFRM) as of Q3 2025, up from 561 in Q2 2025.
- Funds reported $16.6B of Affirm stock for Q3 2025, up 7.1% quarter-over-quarter.
- 151 funds opened new Affirm positions in Q3 2025 and 93 closed out, a net change of +58 holders.
- The largest Affirm buyer in Q3 2025 was Invesco, an estimated $246M added.
- The largest Affirm seller in Q3 2025 was T. Rowe Price Associates, an estimated $197M sold.
Based on aggregated 13F filings for Q3 2025.